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Abstract: 
Background: Cleft lip and palate are congenital disorders which induce affected individuals medically, 
socially and psychologically. The objective of this study was to investigate the association of Single Nucleotide 
Polymorphism(SNP); rs2013162 of IRF6 Gene in Patient with Cleft Lip and Palate. 
Materials and Methods: Fifty patients with non-syndromic CL/P were included in present study alongwith 
fifty individuals with no psychiatric history as controls. In all of the these individuals, search for Single 
nucleotide polymorphism was carried out by designing sequence specific primers. The sequence was amplified 
by using Real time PCR and products were investigated by visualizing high resolution melting curve upon 
HRM-PCR. 
Results: The logistic regression and Hardy-Weinberg equilibrium were applied to investigate the association 
of IRF6 SNP rs2013162 with disease. Results revealed no association of this polymorphism with non-
syndromic CL/P. 
Conclusion: We found no association of IRF6 SNP rs2013162 in patients with non-syndromic CL/P. Further 
study is required with larger sample size to validate the findings of the present study in Pakistani population 
and along with this SNP other polymorphisms of the same gene should be analyzed to find out the association 
with the non-syndromic CL/P. 
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Introduction: 
Cleft lip and palate are considered most 
common birth defects that possess significant 
medical, psychological, social, and financial 
implications on the affected individuals and 
families(1). Cleft lip and palate is a gap, 
which occurs when the lip or roof of the 
mouth does not completely fuse during the 
first trimester of foetal development 
Cleft lip and cleft palate are congenital 
disorders  also known as orofacial cleft, is a 
group of conditions that includes cleft lip 
(CL), cleft palate (CP), and both together (2, 
3). Cleft lip and cleft palate are openings or 
splits in the upper lip, the roof of the mouth 
(4) or both. Cleft lip and cleft palate result 
when facial structures that are developing in 
an unborn baby don't close completely(5). 
Cleft lips come in many shapes and sizes like 
unilateral, bilateral, complete and incomplete 
cleft palate. Clefts of the palate can include 
just the back part of the roof of the mouth 
(soft palate) called a soft palate cleft. They 
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may also include the hard bony part of the 
roof of the mouth (hard palate) (6). 
Anatomically, the philtrum and its pillars are 
a part of the upper lip. The surface of the lip 
is comprised of four zones: hairy skin, 
vermilion border, vermilion and oral mucosa. 
The normal shape of the lips varies with age, 
and is influenced by ethnicity (7). The 
maxillary prominence and medial nasal 
prominence form the upper lip, it is form 
between 6th and 11th week of the 
pregnancy(8). Hard Palate is formed by 
Bones:  Maxilla( Palatine Processes) Soft 
Palate formed by bones Fibromuscular shelf 
attached like a shelf to posterior portion of 
hard palate.(9) Primary Palate Forms during 
4th to 7th week of Gestation Secondary 
Palate Forms in 6th to 9th weeks of 
gestation(10). 
The earliest documented history of cleft lip is 
based on a combination of religion, 
superstition, invention and charlatanism. 
While Greeks ignored their existence, 
Spartans and Romans would kill these 
children as they were considered to Harbour 
evil spirits. When saner senses prevailed 
Fabricius ab Aquapendente (1537–1619) was 
the first to suggest the embryological basis of 
these clefts. The knowledge of cleft lip and 
the surgical correction received a big boost 
during the period between the Renaissance 
and the 19th century with the publication of 
Pierre Franco's Petit Traité and Traité des 
Hernies in which he described the condition 
as “lievré fendu de nativité” (cleft lip present 
from birth). The first documented Cleft lip 
surgery is from China in 390 BC in an 18-
year-old would be soldier, Wey Young-Chi. 
Albucasis of Arabia and his fellow surgeons 
used the cautery instead of the scalpel and 
Yperman in 1854 recommended scarifying 
the margins with a scalpel before suturing 
them with a triangular needle dipped in wax. 
The repair was reinforced by passing a long 
needle through the two sides of the lip and 
fixing the shaft of the needle with a figure-of-
eight thread over the lip. Germanicus Mirault 
can be credited to be the originator of the 
triangular flap which was later modified by 
C.W. Tennison in 1952 and Peter Randall in 
1959. In the late 50s, Ralph Millard gave us 
his legendary ‘cut as you go’ technique. The 
protruding premaxilla of a bilateral cleft lip 
too has seen many changes throughout the 
ages – from being discarded totally to being 
pushed back by wedge resection of vomer to 
finally being left to the orthodontists (11). 
Abnormal anatomy CL\P Vermillion 
(wet/dry border) Cupid’s bow Along the 
upper vermillion cutaneous border (white 
roll), two midline elevations form the bow 
Philtrum Philtral columns and dimple 
Tubercle (12). The complexity of this cranio-
facial developmental pathway and the 
numerous developmental points at which 
clefting could be induced is reflected in the 
heterogeneity of the phenotypic expression of 
the condition. Cleft lip and/or palate: the 
maxillary, medial nasal, and lateral nasal 
prominences converge through a complicated 
process of epithelial bridging, programmed 
cell death, and sub epithelial-mesenchymal 
penetration(13). Cleft lip and/or palate is 
likely to be secondary to a defect of epithelial 
fusion or mesenchymal growth, processes 
involving many possible genetic loci or 
intracellular signalling pathways (14). This 
results in interrupted fusion of the maxillary 
and median nasal prominences. 
Oral clefts have a multifactorial origin and 
are affected by genetic and environmental 
factors. Gender, geographic location, 
nationality, nutritional and peri-conceptional 
consumption of folic acid have an effect on 
the incidence rate of oral clefts (15, 16). It has 
also been reported that tobacco use, 
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antiepileptic drugs and possibly alcohol 
consumption (17), low birth weight (18), and 
mustard gas (19) increase the incidence rate 
of oral clefts in new-borns. Several studies 
have also reported that racial/ethnic 
factors(20, 21) and consanguinity (22).There 
are several other risk factors which causes 
CLP such as :family history, sex, race, 
exposure to certain substances during 
pregnancy, maternal cigarette smoking and 
alcohol consumption during pregnancy, 
having diabetes during pregnancy, being 
obese during pregnancy, X-ray during 
pregnancy and several environmental 
factors(23). Current research continues to 
investigate the extent to which folic acid can 
reduce the incidence of cleft(24) 
Cleft lips and/or palates vary in severity. 
They can range from a small notch in the 
upper lip, to a gaping defect of the lip and 
palate, and sometimes the nose. With a cleft 
palate, the hole in the roof of the mouth 
means there’s a connection between the 
mouth and the nose (25). Cleft lip/cleft palate 
can present a number of obstacles for a child, 
including possible: feeding issues, failure to 
gain weight, flow of milk through nasal 
passages during feeding, poor growth, dental 
and orthodontic problems, speech and 
language difficulties, hearing impairment, 
social and self-esteem challenges (26).  
Orofacial clefting (OFC) is a common birth 
defect with worldwide incidence around 1 in 
700 live births (27). Asian and Amerindian 
populations have the highest birth 
prevalence, often as high as 1/500, with 
European derived populations intermediate at 
about 1/1000, and African-derived 
populations the lowest at 1/2000 (28). The 
study was a 7-year retrospective study from 
March 1998 to March 2005. Twenty-five live 
births with cleft lip and/or palate (CL ± P) 
were born between 20 March 1998 and 20 
March 2005 from the total of 11,651 live 
births in a maternity hospital in Tehran (18). 
Several descriptive epidemiologic studies 
have been carried out in many countries 
worldwide; however, no such study has ever 
been performed in Pakistan. Population-
based data on the incidence of cleft lip and 
palate were obtained from birth registry 
information in northern Pakistan. A total of 
117 cases from 61,156 live births reported 
were identified. The incidence for cleft lip 
and/or cleft palate was 1.91 per 1000 births 
(one per 523 births(29) 
Fogh-Andersen in Denmark first proposed a 
role for genetic factors in NS CL/P ((30). 
Consistent with a multifactorial model of 
inheritance, the aetiology of NS CL/P may be 
explained by the interaction of as few as 2 or 
as many as 14 different genes (31). Several 
approaches have been employed to identify 
genes involved in craniofacial development 
and explain how specific genetic variants 
result in NS CL/P. These genetic approaches 
include genome-wide linkage and association 
analysis as well as study of candidate genes 
studies selected on the basis of genes causing 
syndromic forms of OFC, gene expression, or 
animal models with clefts.(32). Convincing 
genetic and/or biologic evidence exists for 
the contribution of many genes: IRF6, 8q24, 
FGFR2, FOXE1, BMP4, TGFβ3, MSX1, 
MAFB, PAX7, ABCA4, and VAX1, to NS 
CL/P(33) 
Interferon Regulatory Factor 6 (IRF6):  
(IRF6) located on 1q32.2 chromosome and is 
the poorly understood member of a family of 
nine transcription factors with highly 
conserved DNA binding domains and less 
conserved protein binding domains. This 
gene has 4 transcripts (splice variants), 83 
orthologues, 8 paralogues, is a member of 1-
Ensembl protein family and is associated 
with 11 phenotypes. Most IRFs have a role in 
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innate immunity, particularly after viral 
infection, but the role of IRF6 remains 
largely unclear (34). IRF6 acts as a tumor 
suppressor in mammary cells and helps 
induce keratinocyte differentiation (35). 
Mutations in IRF6 cause Van der Woude 
(VWS) and popliteal pterygium syndromes; 
these mutations typically interfere with 
DNA-binding or protein-protein interactions 
of this transcription factor and lead to haplo-
insufficiency of this gene in the affected 
individual(34). 
IRF6 association with NS CL/P has been 
consistently replicated in other populations 
(36-40)  demonstrated by a genome-wide 
linkage scan (41), and a meta-analysis of 13 
linkage studies (42), and has been confirmed 
in all GWA studies in NS CL/P (27, 43). In 
addition to craniofacial defects, animal 
models of IRF6 function exhibit skin and 
limb abnormalities (44). Irf6 is expressed in 
the epidermis of the skin and mice deficient 
for Irf6 exhibit abnormal proliferation and 
differentiation of cutaneous keratinocytes 
(45). This gene is polymorphic and many of 
the SNPs have been associated by various 
researchers and their colleagues with cleft lip 
and palate including rs1319435, rs2235371, 
rs2235375, rs2235543, and rs2013162. 
Polymorphism rs2013162 was analysed to 
test the association of this SNP with the risk 
of developing NSOC, using both case-parent 
trios and cases and controls. 
The purpose of the present study is to recruit 
affected families with CL\P from the 
Pakistani population. From this population, 
molecular studies on large scale have been 
done and many candidate genes have been 
identified in variable phenotypes. In the 
present study, inherited CL\P related 
disorders (where innervations contributed in 
the disease pathway) are the focus for genetic 
studies. In the Pakistani health setup, it 
always remains difficult to diagnose genetic 
diseases due to the lack of required diagnostic 
tools and genetic testing modules. 
Material and Methods: 
Study Design: This was a case-control study. 
Settings: The study was conducted in the 
Department of Human Genetics and 
Molecular Biology, University of Health 
Sciences, Lahore. Samples were collected 
from CLAP Hospital Faisal Town Lahore 
Sample Size: Blood samples from 50 CLP 
patients and 50 sex matched healthy controls 
were taken. 
Sampling Technique: Non-probability 
purposive sampling technique was used to 
collect the data. 
Inclusion Criteria: Case group: Both male 
and female patients with non-syndromic cleft 
lip and palate; control group: Male and 
female general population without cleft lip 
and palate.  
Exclusion criteria: CLP with syndromic 
features will be excluded. 
Sample collection and storage: After an 
informed written consent, all the relevant 
demographic and clinical history was 
collected and recorded in a structured 
questionnaire. Blood samples (3-5 ml) were 
collected from the schizophrenic patients and 
normal subjects, in 0.5 M EDTA (ethylene 
diamine tetra acetate) containing vials. The 
blood was then stored at -20oC until 
processed for DNA isolation. 
DNA Extraction by Salting Out Method:  
1. Autoclaved eppendorf tubes were 
taken and were labeled properly. 
2. 500 μl of blood samples were added 
in the respective tubes. 
3. 700 μl of Tris-EDTA buffer was 
added in all the tubes for the lysis of RBCs. 
4. The lids of the tubes were closed and 
were mixed by vortexing. 
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5. The tubes were left at room 
temperature for 10 to 15 minutes. 
6. They were then centrifuged at 13500 
rpm for 10 minutes. 
7. The supernatant was discarded, and 
the pellet was broken properly by tapping 
with fingers. 
8. Step numbers 3 to 7 were repeated 4 
times but the amount of Tris-EDTA added 
was reduced to 500 μl after the first wash. 
9. After the last wash with Tris-EDTA, 
the pellet was broken again as before and 25 
μl of 10% SDS solution was added 
10. Then 375 μl of sodium acetate and 10 
μl of proteinase K were added respectively. 
11. The solution in the eppendorf tubes 
was mixed properly and they were incubated 
at 37OC for 24 hours. 
12. After 24 hours incubation, the tubes 
were vortexed and 250 to 300 μl of ice cold 
chloroform and iso-amylalcohol (24:1) 
solution was added in each tube. Solution in 
tubes was mixed by inverting them several 
times. 
13. The tubes were centrifuged at 13500 
rpm for 10 min. 
14. After centrifugation, three layers 
were formed in each tube. The central layer 
contained debris and the upper layer 
contained DNA. 
15. The upper layer was transferred into 
new labeled tubes. 
16. Equal volume (500 μl) of cold 
absolute ethanol was added in each tube 
containing the upper layer. It precipitated the 
DNA and the DNA threads were visible after 
inverting the tubes gently 3 to 4 times. 
17. The tubes were left at room 
temperature for 15 to 20 minutes. 
18. The tubes were centrifuged at 13500 
rpm for 10 minutes. 
19. The supernatant was discarded by 
inverting the tubes over layers of tissue 
papers and 500 μl of cold 70% ethanol was 
added in the pellet for washing DNA. 
20. The tubes were centrifuged at 13500 
rpm for 10 minutes. 
21. The supernatant was again discarded 
by inverting the tubes slowly over the layers 
of tissue papers. 
22. The pellet was left to be air dried for 
30 minutes to one hour. 
23. After the pellet got dried, 50 μl of low 
TE was added and DNA was allowed to get 
dissolved in it. 
24. The tubes were incubated at 65OC for 
half an hour to deactivate DNase. 
25. The DNA was finally stored at -20OC 
(46). 
DNA Quality Analysis by Gel 
electrophoresis: 
1. Gel electrophoresis was carried out 
for the detection of DNA isolated from the 
blood. 
2. 2% agarose gel was prepared by 
adding 4g of agarose in 200ml of 1X TBE 
buffer and the solution was heated in 
microwave oven until it became clear. 
3. When the temperature of the solution 
decreased to < 60OC, 10 µl of ethidium 
bromide (10 µg/ml) was mixed in 200 ml of 
the agarose solution. 
4. The gel-casting tray was washed and 
cleaned, and combs were inserted in it. 
5. The gel solution was immediately 
poured into the gel-casting tray before it 
solidified and was then allowed to solidify in 
the tray at room temperature. 
6. After solidification, the gel-casting 
tray containing the gel was shifted into 
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electrophoresis tank having 1X TBE buffer in 
it sufficient to cover the gel surface up to 
2mm. 
7.  The combs were removed smoothly 
after 15 min to allow the gel to be 
equilibrated with buffer. 
8. On a parafilm, 2 µl of DNA was 
mixed in 2µl of 6X loading dye and 8µl of 1X 
TBE buffer. 
9. This mixture was then loaded in the 
wells within the gel alongside a DNA 
ladder/marker containing DNA fragments of 
known concentration. 
10. The power supply was turned on and 
the gel was run from cathode to anode at 150 
volts for half an hour to 45 min until the dye 
reached two third of the gel. 
11. The separated DNA bands on the gel 
were visualized under UV light using gel 
documentation system and the concentration 
of the DNA bands was estimated by 
comparing its intensity with the nearby DNA 
fragment of the DNA ladder/marker. 
DNA Quantity Analysis:  
 The purified DNA samples were quantified 
by Nanodrop analysis (spectrophotometric 
analysis). 10µL of genomic DNA sample 
diluted to 1 ml (dilution factor of 100) with 
autoclaved distilled water was subjected to 
spectrophotometric analysis. The quantity of 
DNA was found by taking absorbance at 260 
Table 1: Gene with its corresponding SNP selected in this study 
No Gene db SNP Allele Position NCBI No. 
Position on 
Sequence 

























IRF6 -F 5’- CAGGGACTGATCCTGCTTTC-3’ 60 
160 bp 
2 IRF6 -R 5’- TGATGTTCAGGAAGGGGAAG-3’ 55 
Hold 
1 
















Figure 1: The thermal cycling conditions for PCR of rs2013162 
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nm and putting the value in the following 
formula. 
DNA quantity (µg/ml) = 50 x optical density 
(OD) at 260nm x dilution factor. 
The quantity of DNA was found to be in 
acceptable range if value is in between 50-70 
ng/µl. 
SNP Selection: 
One SNP was selected in IRF6 gene 
according to the dbSNP 
http://www.ncbi.nlm.nih.gov/snp/ which is 
rs2013162. 
Primer Designing:  
Sequences of selected human genes under 
study were retrieved from NCBI (National 
Centre for Biotechnology Information). 
Sequence was then BLAST (basic local 
alignment tool) in the bioinformatics tool 
(www.genome.ucsc.edu). Using this tool, the 
SNP 2005313 sequence regions was copied 
and saved. The sequence at least 50 base pair 
up and down stream of desired SNP was then 
subjected to primer designing in primer3 
software (www.primer3.com). The designed 
primers were then BLAST in the 
bioinformatics tool. The sequences of the 
primers are given in Table 2. 
Primer reconstitution and dilution: 
100ρmoles oligoes or primers: The nmoles 
of lyophilized oligoes or primers were 
multiplied with 10 and the answer was the 
measure of low TE buffer in µl that was then 
added in lyophilized primers to make 
100ρmoles solution and it was stored at -
20oC. For example, a lyophilized primer 
containing 40.2 nmoles was dissolved in 420 
µl of low TE buffer so the concentration of 
the resultant solution was 0.1 nmoles or 100 
ρmoles.  
10ρmoles oligoes or primers: 100 µl from 
100ρmoles oligoes or primers was mixed 
with 900 µl of distilled water and was stored 
at -20oC. 
PCR optimization: 
Primers were optimized for optimum reaction 
conditions of temperature by using gradient 
PCR. These optimum conditions were then 
used in the experiment. The gradient 
temperatures and optimized annealing 
temperatures for the primers were: 
Table 3: Optimization conditions for 





IRF6 57 oC-64 oC 64oC 
Polymerase Chain Reaction (PCR): 
PCR DreamTaq 2X Master Mix (Thermo 
Scientific) was used for amplification of 
DNA. 1 μl of DNA was amplified by the 
conventional PCR with the optimized 
conditions, using the synthesized forward 
and reverse gene specific primers. The 
reaction mixture was as given in Table 4. The 
optimized cycling conditions for IRF^ 
rs2013162 are shown in Figure 1. 
 
Table 4: Components and 
concentrations of PCR reaction 
Components Concentrations 
DNA 1μl 
Reverse Primer (10 
pm) 
0.5μl 






Nuclease free H2O up to 15.0 μl 
 
Restriction Fragment Length 
Polymorphism: 
Procedure or steps:  
Step I: Restriction digest  
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• Extraction of desired fragments of DNA 
using restriction endonuclease (RE). The 
enzyme RE has specific restriction site on the 
DNA, so it cut DNA into fragments.  
• Different fragments of different sizes was 
generated along with the specific desired 
fragments.  
Step II: Gel electrophoresis  
• The digested fragments were run in agarose 
gel electrophoresis to separate the fragments 
based on size. Different sized fragments form 
different bands.  
Step III: Denaturation 
• The gel was placed in sodium hydroxide 
(NaOH) solution for denaturation so that 
single stranded DNA are formed.  
Step IV: Blotting  
• The single stranded DNA were transferred 
into charge membrane i.e., nitrocellulose 
paper by the process called capillary blotting 
or electro-blotting.  
Step V: Baking and blocking:  
• The nitrocellulose paper transferred with 
DNA was fixed by autoclaving. Then the 
membrane was blocked by using bovine 
serum albumin or casein to prevent binding 







• The labelled 
RFLP probe was 
hybridized with 
DNA on the 
nitrocellulose 
paper. The RFLP 
probes were 
complimentary as 
well as labelled 
with radioactive 
isotopes so they form colour band under 
visualization by autoradiography.  
Result: 
Subjects: The NSCLP patients were 
recruited from CLAP Hospital Faisal Town 
Lahore. After obtaining written informed 
consent from each patient, 50 NSCLP 
patients and 50 healthy controls were 
enrolled in the study. There were 66.0% male 
patients and 37.0% were females. The age of 
the patients ranged from 3 months to above 
18 years. Most patients 33.0% were in the age 
group of 3 months to 5 years and in this group 
the percentage of male patients (30.0%) was 
greater than that of females (20.0%). Figure 
2 illustrates the three age groups of the study 
population.   
Consanguinity was observed to be associated 
with increased risk for as 31.0% of the 
patients were the product of consanguineous 
marriages. CL/P was seen occurring 
commonly in Rajput (9.0%), Arain (9.0%), 
and Jutt (7.0%), families. However, majority 
of the study population belongs to different 
castes like Mughal, Khokhar and Gujjar etc. 



























Figure 2: Age Groups in studied cases and controls
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which reveals that CL/P is not caste specific 
disease. 
In this study, 13 patients out of 50 have Cleft 
lip, 16 patients have cleft palate and 21 have 
both CL, CP. 
In this study 11 patients having SNP were 
presented and 12 patients have cleft lip but 
have no SNP detected. (Chi square= 1.819, p-
value= 0.173) 
Table 5: Association of CL with SNP: 
 
rs2013162 
Total Present Absent 
CL Present 11 1 12 
Absent 27 10 37 

















































Figure 4: Cases distrinution among different castes
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In this study 12 patients having CP showed 
SNP while others have CP but no SNP is 
detected. (Chi square= 3.876, p value=0.57) 
Discussion: 
Orofacial clefting (OFC) is a common birth 
defect with worldwide incidence around 1 in 
700 live births (4). Asian and Amerindian 
populations have the highest birth 
prevalence, often as high as 1/500, with 
European derived populations intermediate at 
about 1/1000, and African-derived 
populations the lowest at 1/2000 (47) cleft lip 
and palate is a gap, which occurs when the lip 
or roof of the mouth does not completely fuse 
during the first trimester of foetal 
development. 
The effect of rs642961 on IRF6 expression 
has been investigated in foreskin 
keratinocytes and lip tissue from cleft 
patients (48) however, this study did not 
identify IRF6 expression differences based 
on SNP genotype for rs2235371 or rs642961. 
Current study was small with only 100 
samples and could have resulted in decreased 
power to detect correlation. In addition, the 
two IRF6 SNPs have low minor allele 
frequencies in Caucasian populations and 
higher minor allele frequencies in Asian 
populations. This study may have failed to 
identify association because our mostly 
Caucasian population is homozygous for the 
common alleles, with 45 heterozygotes and 
only 3 individuals carrying the minor 
homozygous genotype for rs642961 and 10 
heterozygotes and no individuals with the 
homozygous for minor the minor alleles of 
rs2235371. Examining foreskin tissue of an 
Asian population or a population of cleft 
patients may increase the odds of detecting 
the effect of these two IRF6 SNPs on IRF6 
gene expression.   
Developmental genetic studies have shown 
that the mechanisms of disease onset are 
different between NSCL ± P and NSCP. 
Moreover, the incidences of these diseases 
also vary with gender: NSCL ± P is more 
common in men, whereas NSCP is more 
common in women. In a previous study, it 
was found that two SNPs in the transforming 
growth factor alpha (TGFα) gene are 
associated with NSCL ± P, but not NSCP, in 
a northern Chinese population(49) In recent 
years, various investigations have shown the 
IRF6 gene is involved in NSCL/P(50) but 
studies on the association between the IRF6 
gene and risk to NSCP are very limited. In 
this study, the association between the SNPs 
rs2013162 and rs2235371 in IRF6 and NSCP 
in a northeast Chinese population was 
investigated using case-control and case-
parent analysis. 
A study by Jugessur et al. (2008) found a 
significant association between rs2013162 
and NSCP (P = 0.025). In the present study, 
this association was confirmed via case-
control analysis (P < 0.05). Furthermore, 
FBAT analysis showed over-transmission of 
the A allele at rs2013162 (P = 4.472, Z = 
0.001). These results suggested that 
rs2013162 is a “risk allele” for NSCP in the 
northeast Chinese population (51). Its 
previously reported that rs2235371 and 
rs2013162 in the IRF6 gene are significantly 
associated with NSCL/P in a northeast 
Chinese population. Here, we found that 
those two SNPs are strongly associated with 
Table 6: Association of CP with SNP 
 rs2013162 
Total   Present Absent 
 
CP 
Present 12 3 15 
Absent 27 8 35 
Total 39 11 50 
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NSCP in the same population. Jugessur et al. 
(2008) observed that rs2013162, but not 
rs2235371, is associated with NSCP in a 
Norwegian population. These contradicting 
results may be attributed to genetic 
heterogeneity of different populations. 
Conclusion:  
This study found strong association of IRF6 
SNP rs201362 in patients with NSCLP. 
Further study is required with larger sample 
size to validate. It is more common in male 
than females 
Outcome and Utilization: 
Increased understanding of the molecular 
basis of CL/CP will arise from a greater 
understanding of the genes involved in 
disease development, pointing in the 
direction of molecular pathways that may 
lead to CL/CP. This information may help to 
understand the biology of the disease and to 
develop an appropriate  
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